| scholarly article | Q13442814 |
| P356 | DOI | 10.1111/SDI.12294 |
| P698 | PubMed publication ID | 25204879 |
| P2093 | author name string | David Roth | |
| Sharad Virmani | |||
| P2860 | cites work | Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome | Q27860719 |
| Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection | Q27860901 | ||
| Natural history of liver fibrosis progression in patients with chronic hepatitis C. The OBSVIRC, METAVIR, CLINIVIR, and DOSVIRC groups | Q29614459 | ||
| The prevalence of hepatitis C virus infection in the United States, 1999 through 2002 | Q29619974 | ||
| OPTN/SRTR 2011 Annual Data Report: kidney | Q30581465 | ||
| Blood tests to diagnose fibrosis or cirrhosis in patients with chronic hepatitis C virus infection: a systematic review | Q34754575 | ||
| Effect of kidney transplantation on outcomes among patients with hepatitis C | Q35012447 | ||
| Meta-analysis: interferon for the treatment of chronic hepatitis C in dialysis patients | Q35599599 | ||
| Interferon treatment in hemodialysis patients with chronic hepatitis C virus infection: a systematic review of the literature and meta-analysis of treatment efficacy and harms | Q37063767 | ||
| Hepatitis C infection and chronic renal diseases | Q37364331 | ||
| Pegylated interferon monotherapy of chronic hepatitis C in dialysis patients: Meta-analysis of clinical trials | Q37718739 | ||
| Combined antiviral therapy of hepatitis C virus in dialysis patients: meta‐analysis of clinical trials | Q37812399 | ||
| Selection and management of hepatitis C virus-infected patients for the kidney transplant waiting list | Q37981877 | ||
| Noninvasive methods to assess liver disease in patients with hepatitis B or C. | Q38005794 | ||
| Histopathological features of hepatitis C in renal transplant candidates [see comment] | Q41734319 | ||
| Pegylated interferon-α2a with or without low-dose ribavirin for treatment-naive patients with hepatitis C virus genotype 1 receiving hemodialysis: a randomized trial | Q42251577 | ||
| Outcome of hepatitis C virus-infected kidney transplant candidates who remain on the waiting list | Q42989805 | ||
| Patterns of hepatitis C prevalence and seroconversion in hemodialysis units from three continents: the DOPPS. | Q44900472 | ||
| Diagnostic accuracy of the fibrotest in hemodialysis and renal transplant patients with chronic hepatitis C virus | Q45421359 | ||
| Hepatitis C virus infection and de novo glomerular lesions in renal allografts | Q45731872 | ||
| Harmful long-term impact of hepatitis C virus infection in kidney transplant recipients. | Q45757135 | ||
| Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant. | Q50654391 | ||
| Comparison of three algorithms of non-invasive markers of fibrosis in chronic hepatitis C. | Q51509141 | ||
| Trends in incidence and prevalence of major transfusion-transmissible viral infections in US blood donors, 1991 to 1996. Retrovirus Epidemiology Donor Study (REDS) | Q55239955 | ||
| P433 | issue | 5 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | renal dialysis | Q202301 |
| P304 | page(s) | 455-458 | |
| P577 | publication date | 2014-09-01 | |
| P1433 | published in | Seminars in Dialysis | Q15761546 |
| P1476 | title | What are the management issues for hepatitis C in dialysis patients?: management of hepatitis C infection in kidney transplant candidates | |
| P478 | volume | 27 |
| Q39009606 | Epidemiology update for hepatitis C virus and hepatitis B virus in end-stage renal disease in France | cites work | P2860 |
Search more.